- Home
- CUE vs HOLO Comparison
CUE vs HOLO Comparison
Compare CUE & HOLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CUE | HOLO |
|---|---|---|
| Founded | 2014 | 2018 |
| Country | United States | China |
| Employees | N/A | 64 |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.8M | 33.2M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | CUE | HOLO |
|---|---|---|
| Price | $0.26 | $1.97 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 762.9K | 292.0K |
| Earning Date | 03-16-2026 | 08-10-2023 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.11 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $27,466,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $25.00 | N/A |
| P/E Ratio | ★ N/A | $0.16 |
| Revenue Growth | ★ 195.75 | N/A |
| 52 Week Low | $0.23 | $0.36 |
| 52 Week High | $1.05 | $12.75 |
Technical Indicators
Market Signals| Indicator | CUE | HOLO |
|---|---|---|
| Relative Strength Index (RSI) | 38.07 | 36.48 |
| Support Level | $0.23 | N/A |
| Resistance Level | $0.35 | $2.30 |
| Average True Range (ATR) | 0.03 | 0.13 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 18.42 | 0.00 |
Price Performance
Historical ComparisonAbout CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
About HOLO MicroCloud Hologram Inc.
MicroCloud Hologram Inc, through its subsidiaries, is mainly engaged in holographic Technology. It includes Holographic solutions and Holographic technology services. The company also provides holographic digital twin technology services for customers and has built a holographic digital twin technology resource library. Geographically company is operating in single segment, China.